About SleepioRx
SleepioRx is an FDA-cleared prescription digital therapeutic that delivers guideline-recommended cognitive behavioral therapy for insomnia (CBT-I) through personalized video and audio lessons in a mobile app. Designed by sleep experts, the treatment helps patients understand unhealthy sleep patterns and address the thoughts and behaviors that sustain insomnia. The program has been tested in 26 clinical trials including 18 randomized controlled trials, demonstrating that up to 76% of patients achieve healthy sleep by post-treatment with benefits lasting 1 year or longer. As the first digital therapeutic to receive NICE guidance in the UK confirming clinical and cost effectiveness, SleepioRx is now reimbursable under Medicare with CMS billing codes effective January 2025.
Best For
- • Sleep medicine specialists
- • psychiatrists
- • and primary care providers treating patients with chronic insomnia who may benefit from non-pharmacological treatment
Not Ideal For
- • Patients with sleep apnea or other primary sleep disorders requiring medical intervention beyond behavioral therapy
Pricing
Contact for pricing
Compliance & Security
Always verify compliance directly with the vendor.
Target Audience
Roles
Settings
Related Tools
DaylightRx
FDA-cleared CBT digital therapeutic for anxiety
Sleepio (SleepioRx)
FDA-cleared CBT-I digital therapeutic for chronic insomnia with 76% improvement rate.
Akili Interactive (EndeavorRx, EndeavorOTC)
First FDA-cleared video game digital therapeutic for ADHD in children and adults.
Big Health (Sleepio, Daylight)
First FDA-cleared DTx for anxiety (DaylightRx) and insomnia (SleepioRx) with Medicare coverage.